Shire PLC (ADR) (SHPG) Reaches $137.95 52-Week Low; Winthrop Resources (UBSH) Sentiment Is 1.53

October 26, 2017 - By Hazel Jackson

The stock of Shire PLC (ADR) (NASDAQ:SHPG) hit a new 52-week low and has $125.53 target or 9.00% below today’s $137.95 share price. The 8 months bearish chart indicates high risk for the $41.20B company. The 1-year low was reported on Oct, 26 by Barchart.com. If the $125.53 price target is reached, the company will be worth $3.71B less. About 1.14M shares traded or 19.83% up from the average. Shire PLC (ADR) (NASDAQ:SHPG) has risen 4.69% since October 26, 2016 and is uptrending. It has underperformed by 12.01% the S&P500.

Union Bankshares Corporation is a financial holding firm and bank holding company. The company has market cap of $1.54 billion. The Firm operates through two divisions: a community bank segment and mortgage loan origination business segment. It has a 19.57 P/E ratio. The Firm offers financial services through its community bank subsidiary, Union Bank & Trust and three non-bank financial services affiliates.

Analysts await Shire PLC (ADR) (NASDAQ:SHPG) to report earnings on October, 27 before the open. They expect $3.66 earnings per share, up 15.46% or $0.49 from last year’s $3.17 per share. SHPG’s profit will be $1.09 billion for 9.42 P/E if the $3.66 EPS becomes a reality. After $3.73 actual earnings per share reported by Shire PLC (ADR) for the previous quarter, Wall Street now forecasts -1.88% negative EPS growth.

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The company has market cap of $41.20 billion. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It has a 60.74 P/E ratio. It focuses its development resources on projects in various therapeutic areas , including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Among 24 analysts covering Shire plc (ADR) (NASDAQ:SHPG), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Shire plc (ADR) had 54 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, November 3 by HSBC. The firm earned “Hold” rating on Thursday, July 6 by HSBC. On Friday, September 1 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm has “Buy” rating by Jefferies given on Friday, October 6. The stock of Shire PLC (ADR) (NASDAQ:SHPG) earned “Outperform” rating by Credit Suisse on Tuesday, January 12. JP Morgan maintained Shire PLC (ADR) (NASDAQ:SHPG) on Friday, May 20 with “Overweight” rating. Stifel Nicolaus maintained it with “Buy” rating and $245.0 target in Friday, October 6 report. The rating was reinitiated by Morgan Stanley on Friday, June 3 with “Overweight”. The rating was maintained by Cantor Fitzgerald on Friday, June 30 with “Buy”. The rating was maintained by Jefferies with “Buy” on Friday, June 9.